California passed a law last year aimed at controlling rising healthcare costs that gave the state the ability to scrutinize healthcare deals of a certain size involving California companies. What impact can it have?

The Biden administration on Tuesday unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off a controversial process that aims to make costly medications more affordable for older Americans.

Blue Shield of California shocked a lot of people when it announced it was going to drop CVS Health (CVS) as its main pharmacy benefit manager (PBM) and instead go with companies like Amazon Pharmacy (AMZN) and Mark Cuban's Cost Plus Drugs.

Many steps remain before older adults see the benefit of the Centers for Medicare and Medicaid Services’ upcoming talks with drugmakers.

If Gov. Gavin Newsom was hoping amendments introduced to his mental health overhaul last week would sufficiently appease critics, Tuesday’s back-to-back committee hearings only revealed how much further he has to go to reach a compromise. The big idea: Newsom wants counties to prioritize behavioral health spending on homeless individuals who have serious mental illness or addiction ...

The national Covid emergency has ended, but a new strain of the coronavirus, called EG.5 or “Eris,” is rapidly circulating worldwide. “EG.5 is actually just a subvariant of omicron,” says Dr. Payal Patel, infectious diseases physician at Intermountain Health in Salt Lake City. “We are seeing a rise in this subvariant worldwide. We’re seeing it in the U.S. ...